Seizures in dominantly inherited Alzheimer disease

Neurology

Volumn 87, Issue 9, 2016, Pages 912-919

  Zarea, Aline ^a   Charbonnier, Camille ^b   Rovelet Lecrux, Anne ^b   Nicolas, Gaël ^a,b   Rousseau, Stéphane ^a,b   Borden, Alaina ^a   Pariente, Jeremie ^c   Le Ber, Isabelle ^d   Pasquier, Florence ^e   Formaglio, Maite ^f   Martinaud, Olivier ^a   Rollin Sillaire, Adeline ^e   Sarazin, Marie ^g   Croisile, Bernard ^f   Boutoleau Bretonnière, Claire ^h   Ceccaldi, Mathieu ⁱ   Gabelle, Audrey ^j   Chamard, Ludivine ^k   Blanc, Frédéric ^l   Sellal, François ⁿ   Paquet, Claire ^m   Campion, Dominique ^a,b   Hannequin, Didier ^a,b   Wallon, David ^a,b   more..

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c CHU PURPAN   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e CHU Lille   (France)

^f Groupe Hospitalier Est   (France)

^g CENTRE HOSPITALIER SAINTE ANNE   (France)

^h NANTES UNIVERSITY HOSPITAL   (France)

ⁱ AIX MARSEILLE UNIVERSITY   (France)

^j MONTPELLIER UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY HOSPITAL OF BESANÇON   (France)

^l UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^m HÔPITAL LARIBOISIÈRE   (France)

ⁿ NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MEMBRANE PROTEIN; PRESENILIN 1; PRESENILIN 2; PSEN1 PROTEIN, HUMAN; PSEN2 PROTEIN, HUMAN;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT EARLY ONSET ALZHEIMER DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; FOLLOW UP; FRANCE; GENE DUPLICATION; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; ONSET AGE; PRIORITY JOURNAL; PROTEIN DOMAIN; RISK FACTOR; SEIZURE; AGED; CLINICAL TRIAL; DNA MUTATIONAL ANALYSIS; EPILEPSY; GENETICS; MUTATION; NONPARAMETRIC TEST; YOUNG ADULT;

ADULT; AGE OF ONSET; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; EPILEPSY; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MUTATION; PRESENILIN-1; PRESENILIN-2; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84984848117     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003048     Document Type: Article

References (39)

1. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia, and adult-onset unprovoked seizures. Neurology 1996; 46: 727-730
2. Imfeld P, Bodmer M, Schuerch M, Jick SS, Meier CR. Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis. Epilepsia 2013; 54: 700-707
3. Friedman D, Honig LS, Scarmeas N. Seizures, and epilepsy in Alzheimer's disease. CNS Neurosci Ther 2012; 18: 285-294
4. Mendez MF, Catanzaro P, Doss RC, Arguello R, Frey WH. Seizures in Alzheimer's disease: clinicopathologic study. J Geriatr Psychiatry Neurol 1994; 7: 230-233
5. Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer's disease is a risk factor for lateonset seizures. Arch Neurol 1990; 47: 847-850
6. Scarmeas N, Honig LS, Choi H, et al. Seizures in Alzheimer disease: who, when, and how common? Arch Neurol 2009; 66: 992-997
7. Irizarry MC, Jin S, He F, et al. Incidence of new-onset seizures in mild to moderate Alzheimer disease. Arch Neurol 2012; 69: 368-372
8. Wallon D, Rousseau S, Rovelet-Lecrux A, et al. The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum, and cerebrospinal fluid biomarkers. J Alzheimers Dis 2012; 30: 847-856
9. Larner AJ. Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships. J Alzheimers Dis 2013; 37: 653-659
10. Shea YF, Chu LW, Chan AO, Ha J, Li Y, Song YQ. A systematic review of familial Alzheimer's disease: differences in presentation of clinical features among three mutated genes, and potential ethnic differences. J Formos Med Assoc 2016; 115: 67-75
11. Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures, and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE), and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46: 470-472
12. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology, and concepts for organization of seizures, and epilepsies: report of the ILAE Commission on Classification, and Terminology, 2005-2009. Epilepsia 2010; 51: 676-685
13. Proposal for revised classification of epilepsies, and epileptic syndromes. Commission on Classification, and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30: 389-399
14. Rovelet-Lecrux A, Hannequin D, Raux G, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 2006; 38: 24-26
15. Guerreiro RJ, Baquero M, Blesa R, et al. Genetic screening of Alzheimer's disease genes in Iberian, and African samples yields novel mutations in presenilins, and APP. Neurobiol Aging 2010; 31: 725-731
16. Rascovsky K, Salmon DP, Lipton AM, et al. Rate of progression differs in frontotemporal dementia, and Alzheimer disease. Neurology 2005; 65: 397-403
17. Linn J, Halpin A, Demaerel P, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 2010; 74: 1346-1350
18. Pottier C, Wallon D, Lecrux AR, et al. Amyloid-b protein precursor gene expression in Alzheimer's disease, and other conditions. J Alzheimers Dis 2012; 28: 561-566
19. Cabrejo L, Guyant-Maréchal L, Laquerrière A, et al. Phenotype associated with APP duplication in five families. Brain 2006; 129: 2966-2976
20. Guyant-Marechal I, Berger E, Laquerriere A, et al. Intrafamilial diversity of phenotype associated with app duplication. Neurology 2008; 71: 1925-1926
21. Lott IT, Doran E, Nguyen VQ, Tournay A, Movsesyan N, Gillen DL. Down syndrome, and dementia: seizures, and cognitive decline. J Alzheimers Dis 2012; 29: 177-185
22. Mann DM, Pickering-Brown SM, Takeuchi A, Iwatsubo T, Members of the Familial Alzheimer's Disease Pathology Study Group. Amyloid angiopathy, and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. Am J Pathol 2001; 158: 2165-2175
23. Palop JJ, Mucke L, Roberson ED. Quantifying biomarkers of cognitive dysfunction, and neuronal network hyperexcitability in mouse models of Alzheimer's disease: depletion of calcium-dependent proteins, and inhibitory hippocampal remodeling. Methods Mol Biol 2011; 670: 245-262
24. Born HA, Kim JY, Savjani RR, et al. Genetic suppression of transgenic APP rescues hypersynchronous network activity in a mouse model of Alzheimer's disease. J Neurosci 2014; 34: 3826-3840
25. Palop JJ, Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci 2010; 13: 812-818
26. Menéndez M. Down syndrome, Alzheimer's disease, and seizures. Brain Dev 2005; 27: 246-252
27. Kauwe JS, Wang J, Chakraverty S, Goate AM, Henao-Martinez AF. Novel presenilin 1 variant (P117A) causing Alzheimer's disease in the fourth decade of life. Neurosci Lett 2008; 438: 257-259
28. Kumar-Singh S. Hereditary, and sporadic forms of Abetacerebrovascular amyloidosis, and relevant transgenic mouse models. Int J Mol Sci 2009; 10: 1872-1895
29. Ikeuchi T, Kaneko H, Miyashita A, et al. Mutational analysis in early-onset familial dementia in the Japanese population: the role of PSEN1, and MAPT R406W mutations. Dement Geriatr Cogn Disord 2008; 26: 43-49
30. Berezovska O, Lleó A, Herl LD, et al. Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin, and interactions with amyloid precursor protein. J Neurosci 2005; 25: 3009-3017
31. Larner AJ, Doran M. Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update. J Alzheimers Dis 2009; 17: 259-265
32. Larner AJ. Presenilin-1 mutation Alzheimer's disease: a genetic epilepsy syndrome? Epilepsy Behav 2011; 21: 20-22
33. Jayadev S, Leverenz JB, Steinbart E, et al. Alzheimer's disease phenotypes, and genotypes associated with mutations in presenilin 2. Brain 2010; 133: 1143-1154
34. Edwards-Lee T, Ringman JM, Chung J, et al. An African American family with early-onset Alzheimer disease, and an APP (T714I) mutation. Neurology 2005; 64: 377-379
35. Born HA. Seizures in Alzheimer's disease. Neuroscience 2015; 286: 251-263
36. Vossel KA, Beagle AJ, Rabinovici GD, et al. Seizures, and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol 2013; 70: 1158-1166
37. Smith SJ. EEG in the diagnosis, classification, and management of patients with epilepsy. J Neurol Neurosurg Psychiatry 2005; 76(suppl 2): 2-7
38. Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf 2002; 25: 91-110
39. Morris JC, Aisen PS, Bateman RJ, et al. Developing an international network for Alzheimer research: the Dominantly Inherited Alzheimer Network. Clin Investig 2012; 2: 975-984